[HTML][HTML] COE loss-of-function analysis reveals a genetic program underlying maintenance and regeneration of the nervous system in planarians

MW Cowles, KC Omuro, BN Stanley… - PLoS …, 2014 - journals.plos.org
Members of the COE family of transcription factors are required for central nervous system
(CNS) development. However, the function of COE in the post-embryonic CNS remains …

[HTML][HTML] DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage

GS Watts, BW Futscher, N Holtan, K DeGeest… - BMC medical …, 2008 - Springer
Abstract Background Hypermethylation of promoter CpG islands with associated loss of
gene expression, and hypomethylation of CpG-rich repetitive elements that may destabilize …

Identification of HRK as a Target of Epigenetic Inactivation in Colorectal and Gastric Cancer

T Obata, M Toyota, A Satoh, Y Sasaki, K Ogi… - Clinical cancer …, 2003 - AACR
Abstract Purpose: Aberrant methylation of CpG islands can be a good molecular marker for
identifying genes inactivated in cancer. We found the proapoptotic gene HRK to be a target …

Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth

C Hong, KS Moorefield, P Jun… - Proceedings of the …, 2007 - National Acad Sciences
Human cancer genome and epigenome projects aim to identify new cancer genes and
targets for therapy that have been overlooked by conventional approaches. Here we …

Genome–epigenome interactions in cancer

RM Brena, JF Costello - Human molecular genetics, 2007 - academic.oup.com
Genetic and epigenetic mechanisms contribute to the development of human tumors.
However, the conventional analysis of neoplasias has preferentially focused on only one of …

Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas

R Wu, L Lin, DG Beer, LH Ellenson, BJ Lamb… - The American journal of …, 2003 - Elsevier
Gene amplification is an important mechanism of oncogene activation in various human
cancers, including ovarian carcinomas (OvCas). We used restriction landmark genomic …

Epigenetics: differential DNA methylation in mammalian somatic tissues

H Nagase, S Ghosh - The FEBS journal, 2008 - Wiley Online Library
Epigenetics refers to heritable phenotypic alterations in the absence of DNA sequence
changes, and DNA methylation is one of the extensively studied epigenetic alterations. DNA …

Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma

Y Gui, M Yeganeh, YC Donates, WS Tobelaim… - Oncogene, 2015 - nature.com
Suppressor of cytokine signaling 1 (SOCS1) is considered as a tumor suppressor protein in
hepatocellular carcinoma (HCC), but the underlying mechanisms remain unclear …

An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis

LY Zhao, Y Niu, A Santiago, J Liu, SH Albert… - Cancer research, 2006 - AACR
In a genome-wide screen for putative tumor suppressor genes, the EBF3 locus on the
human chromosome 10q26. 3 was found to be deleted or methylated in 73% of the …

Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific

P Jun, C Hong, A Lal, JM Wong, MW McDermott… - Neuro …, 2009 - academic.oup.com
Both genetic and epigenetic mechanisms contribute to meningioma development by altering
gene expression and protein function. To determine the relative contribution of each …